EXOSKIN

Here are some ways AD-MSC exosomes may contribute to wrinkle treatment:

When MSC-derived exosomes are combined with autologous fat transfer (also known as fat grafting) for skin filler treatments, they can potentially enhance the therapeutic effects and improve the longevity and quality of the treatment. The mode of action of MSC-derived exosomes in skin filler treatment with autologous fat support involves several mechanisms:

Enhancing fat graft survival:
MSC-derived exosomes can promote the survival of adipocytes (fat cells) and other cells within the fat graft by providing growth factors, cytokines, and other signaling molecules that support cell proliferation, differentiation, and survival. This may help to increase the survival rate of the transferred fat and improve the overall results of the treatment.

Angiogenesis:
Exosomes can stimulate the formation of new blood vessels in the transplanted fat tissue by transferring pro-angiogenic factors, such as vascular endothelial growth factor (VEGF), to endothelial cells. This improves blood supply to the graft, enhancing its survival and integration with the surrounding tissue.

Immunomodulation:
MSC-derived exosomes can modulate the immune response in the recipient tissue, suppressing inflammation and promoting tissue repair. This can help to reduce potential side effects and complications associated with autologous fat transfer procedures.

Extracellular matrix (ECM) remodeling:
MSC-derived exosomes can regulate the synthesis and degradation of extracellular matrix proteins, such as collagen, elastin, and hyaluronic acid, which are essential for maintaining skin structure and hydration. This can help to improve the quality of the transplanted fat tissue and its integration with the surrounding skin.

Skin rejuvenation:
In addition to supporting the fat graft, MSC-derived exosomes can also exert direct effects on the skin, promoting the proliferation and migration of fibroblasts and keratinocytes, stimulating collagen synthesis, and protecting skin cells from oxidative stress. These effects can help to improve skin elasticity, firmness, and texture, enhancing the overall results of the treatment.

By combining MSC-derived exosomes with autologous fat transfer, it is possible to leverage the regenerative and reparative properties of both components to achieve improved outcomes in skin filler treatments.

Mesenchymal stem cell (MSC)-derived exosomes combined with autologous fat transfer can be a promising option for skin filler treatments. Ideal patients for this approach may include those who:

Seek a more natural alternative: Patients looking for a more natural and biocompatible option for skin filler treatments, as opposed to synthetic fillers, may find this combination approach suitable. Autologous fat transfer utilizes the patient’s own fat, and MSC-derived exosomes are derived from the patient’s own cells, reducing the risk of allergic reactions or rejection.

Desire longer-lasting results: Autologous fat transfer with MSC-derived exosomes may provide longer-lasting results compared to traditional hyaluronic acid-based fillers, as the adipocytes (fat cells) can integrate with the surrounding tissue and provide a more stable volume restoration.

Have age-related volume loss: Patients experiencing age-related volume loss in the face or hands, leading to hollows, wrinkles, or fine lines, may benefit from this combination treatment. The MSC-derived exosomes can promote skin rejuvenation and repair, while the autologous fat transfer can restore lost volume.

Require soft tissue contouring: Patients who have irregularities or asymmetries in their soft tissue contour, such as those resulting from injury, surgery, or congenital conditions, may find the combination treatment beneficial for improving the appearance and texture of the affected area.

Have good donor fat availability: Ideal patients should have sufficient fat deposits in other areas of the body that can be harvested for the autologous fat transfer procedure, such as the abdomen, thighs, or buttocks.

Are in overall good health: Patients should be in good general health, with no active infections, uncontrolled medical conditions, or contraindications to surgery. Good health increases the likelihood of successful treatment and reduces potential risks and complications.

Exosomes are extracted from human mesenchymal stem cells and thoroughly tested for quality and quantity. Containing valuable lipids, messenger RNA, cytokines, and proteins, our bank of Exosomes will be administered accordingly with the Specialist recommendation.

With its specialized laboratories housing all the equipment needed to carry out any Exosome treatment successfully, Bioscience is the only clinic with the ability to help patients achieve the desired results. Before any procedure, extensive steps are taken to ensure that all products undergo a strict screening process that certifies sterility, safety for use, and endotoxin testing.

Request now a free consultation on EXOSKIN – Exosome treatment for Wrinkles, the new frontier in regenerative medicine. Email info@bioinst.com or fill out the form below to be contacted by one of our experts.

(*) Required fields